share_log

Timken to Announce First-Quarter 2024 Financial Results on April 30

PR Newswire ·  Apr 11 06:51

NORTH CANTON, Ohio, April 11, 2024 /PRNewswire/ -- The Timken Company (NYSE: TKR; ), a global leader in engineered bearings and industrial motion products, will release its first-quarter 2024 financial results on Tuesday, April 30, prior to the opening of the New York Stock Exchange. The company will host a conference call that day to discuss its financial performance with investors and securities analysts. The financial results and conference call materials will be available online at

Conference Call:

Timken's Q1 2024 Earnings Results


Tuesday, April 30, 2024


11:00 a.m. Eastern Time


Live Dial-In: 833-470-1428


or 404-975-4839


Access Code: 660675


(Call in 10 minutes prior to be included.)



Conference Call Replay:

Replay Dial-In available through


May 14, 2024:


866-813-9403 or 929-458-6194


Replay Access Code: 639103



Live Webcast:

About The Timken Company
The Timken Company (NYSE: TKR; ) designs a growing portfolio of engineered bearings and industrial motion products. With more than a century of knowledge and innovation, we continuously improve the reliability and efficiency of global machinery and equipment to move the world forward. Timken posted $4.8 billion in sales in 2023 and employs more than 19,000 people globally, operating from 45 countries. Timken is one of the World's Most Innovative Companies, according to Fast Company, and has been recognized among America's Most Responsible Companies and America's Greatest Workplaces for Diversity by Newsweek, the World's Most Ethical Companies by Ethisphere and America's Most Innovative Companies by Fortune.

Media Relations:
Scott Schroeder
234.262.6420
[email protected]

Investor Relations:
Meghan Elmblad
234.262.7112
investors@timken.com

SOURCE The Timken Company

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment